These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1312901)

  • 21. Role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cells.
    van der Burg B; Isbrücker L; van Selm-Miltenburg AJ; de Laat SW; van Zoelen EJ
    Cancer Res; 1990 Dec; 50(24):7770-4. PubMed ID: 2174732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factor II binding and action in human fetal fibroblasts.
    Conover CA; Rosenfeld RG; Hintz RL
    J Cell Physiol; 1987 Dec; 133(3):560-6. PubMed ID: 2961773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IGF-II receptor number is increased in TE-85 osteosarcoma cells by combined magnetic fields.
    Fitzsimmons RJ; Ryaby JT; Magee FP; Baylink DJ
    J Bone Miner Res; 1995 May; 10(5):812-9. PubMed ID: 7639117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
    Osborne CK; Coronado EB; Kitten LJ; Arteaga CI; Fuqua SA; Ramasharma K; Marshall M; Li CH
    Mol Endocrinol; 1989 Nov; 3(11):1701-9. PubMed ID: 2558302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of insulin like growth factor II autocrine growth of Wilms' tumor by suramin in vitro and in vivo.
    Vincent TS; Hazen-Martin DJ; Garvin AJ
    Cancer Lett; 1996 May; 103(1):49-56. PubMed ID: 8616808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II.
    Mathieu M; Rochefort H; Barenton B; Prebois C; Vignon F
    Mol Endocrinol; 1990 Sep; 4(9):1327-35. PubMed ID: 2172799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of suramin on 125I-insulin-like growth factor-I binding to human meningiomas and on proliferation of meningioma cells.
    Tsutsumi K; Kitagawa N; Niwa M; Himeno A; Taniyama K; Shibata S
    J Neurosurg; 1994 Mar; 80(3):502-9. PubMed ID: 8113863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop.
    Schrell UM; Gauer S; Kiesewetter F; Bickel A; Hren J; Adams EF; Fahlbusch R
    J Neurosurg; 1995 Apr; 82(4):600-7. PubMed ID: 7897522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The type II insulin-like growth factor receptor does not mediate deoxyribonucleic acid synthesis in human fibroblasts.
    Furlanetto RW; DiCarlo JN; Wisehart C
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1142-9. PubMed ID: 2952664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IGF-I and IGF-I receptor in mouse colon cancer cells.
    Singh P; Guo YS; Narayan S; Chandrasekhar Y
    In Vitro Cell Dev Biol; 1991 Oct; 27A(10):755-8. PubMed ID: 1660048
    [No Abstract]   [Full Text] [Related]  

  • 31. Suramin inhibits growth and yet promotes insulin-like growth factor II expression in HepG2 cells.
    Kraft A; Reid LM; Zvibel I
    Cancer Res; 1993 Feb; 53(3):652-7. PubMed ID: 8381048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type I and type II insulin-like growth factor receptors and their function in human Ewing's sarcoma cells.
    van Valen F; Winkelmann W; Jürgens H
    J Cancer Res Clin Oncol; 1992; 118(4):269-75. PubMed ID: 1315779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pitfalls in insulin-like growth factor (IGF) receptor binding studies using cells in monolayer culture.
    Duclos MJ; Goddard C
    Horm Metab Res; 1991 Nov; 23(11):562-4. PubMed ID: 1667776
    [No Abstract]   [Full Text] [Related]  

  • 34. Insulin-like growth factors are mitogenic for human keratinocytes and a squamous cell carcinoma.
    Neely EK; Morhenn VB; Hintz RL; Wilson DM; Rosenfeld RG
    J Invest Dermatol; 1991 Jan; 96(1):104-10. PubMed ID: 1846163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suramin blockade of insulinlike growth factor I-stimulated proliferation of human osteosarcoma cells.
    Pollak M; Richard M
    J Natl Cancer Inst; 1990 Aug; 82(16):1349-52. PubMed ID: 2166171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of growth stimulation by suramin in non-small-cell lung cancer cell lines.
    Lokshin A; Peng X; Campbell PG; Barsouk A; Levitt ML
    Cancer Chemother Pharmacol; 1999; 43(4):341-7. PubMed ID: 10071987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin like growth factor I is an autocrine regulator of human colon cancer cell differentiation and growth.
    Baghdiguian S; Verrier B; Gerard C; Fantini J
    Cancer Lett; 1992 Feb; 62(1):23-33. PubMed ID: 1311629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells.
    Stracke ML; Engel JD; Wilson LW; Rechler MM; Liotta LA; Schiffmann E
    J Biol Chem; 1989 Dec; 264(36):21544-9. PubMed ID: 2557332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells.
    Stewart AJ; Johnson MD; May FE; Westley BR
    J Biol Chem; 1990 Dec; 265(34):21172-8. PubMed ID: 2174437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The presence of classical insulin-like growth factor (IGF) type-I and -II receptors on mouse osteoblasts: autocrine/paracrine growth effect of IGFs?
    Slootweg MC; Hoogerbrugge CM; de Poorter TL; Duursma SA; van Buul-Offers SC
    J Endocrinol; 1990 May; 125(2):271-7. PubMed ID: 2165120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.